Efficacy and Safety of AVE1625 as a co-Treatment With Antipsychotic Therapy in Schizophrenia - Related Studies

Home

Study Topics

Glossary


	Full Text View


	Tabular View


	Contacts and Locations


	No Study Results Posted


	Related Studies

Efficacy and Safety of AVE1625 as a co-Treatment With Antipsychotic Therapy in Schizophrenia (CONNECT)

This study is currently recruiting participants.

Study NCT00439634. Last updated on September 19, 2008. Information provided by Sanofi-Aventis

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Schizophrenia

2	More general conditions related to this trial
		Mental Disorders
		Schizophrenia and Disorders with Psychotic Features

3	Interventions listed in this trial
		AVE1625
		placebo

4	Sponsors listed in this trial
		Sanofi-Aventis